These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 204604)
21. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen. Sairenji T; Nguyen QV; Woda B; Humphreys RE J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803 [TBL] [Abstract][Full Text] [Related]
22. Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-Iododeoxyuridine. Sugawara K; Osato T Nat New Biol; 1973 Nov; 246(151):72-3. PubMed ID: 4357309 [No Abstract] [Full Text] [Related]
23. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate. Roubal J; Luka J; Klein G Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939 [TBL] [Abstract][Full Text] [Related]
24. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J; Pai S; Cotter M; Robertson ES Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337 [TBL] [Abstract][Full Text] [Related]
25. Host cell regulation of induction of Epstein-Barr virus. Glaser R; Nonoyama M J Virol; 1974 Jul; 14(1):174-6. PubMed ID: 4365330 [TBL] [Abstract][Full Text] [Related]
26. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine. Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498 [No Abstract] [Full Text] [Related]
27. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Moar MH; Ber R; Klein G; Westman A; Eriksson I Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545 [TBL] [Abstract][Full Text] [Related]
28. Detection of antigens determined by the Epstein Barr virus (EBV) in human lymphoblastoid cell culture lines by elution of specific radioiodine labeled antibody. Lamon EW; Ernberg I; Klein G Clin Immunol Immunopathol; 1974 Jan; 2(2):216-33. PubMed ID: 4361279 [No Abstract] [Full Text] [Related]
29. Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. Ben-Sasson SA; Klein G Int J Cancer; 1981 Aug; 28(2):131-5. PubMed ID: 6172387 [TBL] [Abstract][Full Text] [Related]
30. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines. Lidin BI; Lamon EW; Cloud G; Soong SJ Intervirology; 1982; 18(1-2):66-75. PubMed ID: 6288617 [TBL] [Abstract][Full Text] [Related]
31. Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines. Adams A; Lidin B; Strander H; Cantell K J Gen Virol; 1975 Aug; 28(2):219-23. PubMed ID: 170371 [TBL] [Abstract][Full Text] [Related]
32. Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Pritchett R; Pedersen M; Kieff E Virology; 1976 Oct; 74(1):227-31. PubMed ID: 18625461 [TBL] [Abstract][Full Text] [Related]
33. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus. Klein G; Falk L; Falk K Intervirology; 1978; 10(3):153-64. PubMed ID: 210135 [TBL] [Abstract][Full Text] [Related]
34. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay. Brown TD; Ernberg I; Lamon EW; Klein G Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574 [No Abstract] [Full Text] [Related]
35. Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells. Bister K; Yamamoto N; zur Hausen H Int J Cancer; 1979 Jun; 23(6):818-25. PubMed ID: 89100 [TBL] [Abstract][Full Text] [Related]
36. The spontaneous and induced synthesis of Epstein-Barr virus antigens in Raji cells immobilized on surface coated with anti-lymphocyte globulin. Bayliss GJ; Wolf H J Gen Virol; 1981 Jun; 54(Pt 2):397-401. PubMed ID: 6270256 [TBL] [Abstract][Full Text] [Related]
37. Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine. Souyri-Caporale M; Tovey MG; Ono K; Jasmin C; Chermann JC J Gen Virol; 1984 Apr; 65 ( Pt 4)():831-5. PubMed ID: 6323625 [TBL] [Abstract][Full Text] [Related]
38. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines. Sugawara K; Mizuno F; Osato T Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346 [No Abstract] [Full Text] [Related]
40. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]